NDC 17033-282 - Vetromax
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17033-282
- Package NDCs from labels
- 17033-282-75, 17033-282-15
- Manufacturer
- Dechra Veterinary Products | Fougera Pharmaceuticals Inc.
- Effective date
- 2021-10-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Vetromax - Dechra Veterinary Products | Fougera Pharmaceuticals Inc. | Dechra Veterinary Products | Fougera Pharmaceuticals Inc. | 2021-10-21 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FifthPulse Clotrimazole Antifungal | CLOTRIMAZOLE | WeCare Products LLC | 9f5ea297-5a25-42cc-bd47-4159108b0023 | 2026-04-27 | Warnings | G07GZ97H65 |
| Mineral Oil | MINERAL OIL | Publix Supermarkets, Inc. | 382a57d1-85bf-480f-9967-f85da2904410 | 2026-04-23 | Warnings | T5L8T28FGP |
| SimplyVital Antifungal Clotrimazole | CLOTRIMAZOLE | Alpha Plants Inc | 44881106-3ab4-4103-9c48-1da435ab5b13 | 2026-04-16 | Warnings | G07GZ97H65 |
| Equaline Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | United Natural Foods, Inc. dba UNFI | a6ed1987-37ad-4bfd-8cea-f03426953f5a | 2026-04-16 | Warnings | T5L8T28FGP |
| Clotrimazole Topical Solution USP, 1% | CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% | Allegis Holdings, LLC | 529bb597-b291-42fb-b45f-744a55df64f1 | 2026-04-09 | Warnings, Adverse reactions | G07GZ97H65 |
| RoyceDerm Tinea ANTIFUNGAL .soap. | CLOTRIMAZOLE 1% | RoyceDerm LLC | 4e889f2b-9ea1-b1a6-e063-6394a90a4654 | 2026-04-03 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Preferred Pharmaceuticals Inc. | 70e1efac-1738-43db-b19c-bbe02810b6e7 | 2026-04-01 | Warnings | G07GZ97H65 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Sportpharm LLC | 313dde2e-fb82-4786-988b-565d3e003c37 | 2026-04-01 | Warnings, Adverse reactions | G07GZ97H65 |
| RUGBY ANTIFUNGAL CLOTRIMAZOLE | CLOTRIMAZOLE | Preferred Pharmaceuticals Inc. | caba588a-13df-4035-ac41-6b4ec90cd88d | 2026-04-01 | Warnings | G07GZ97H65 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Preferred Pharmaceuticals Inc. | 196e24fc-3315-4366-ad40-51b7ea54b211 | 2026-04-01 | Warnings, Adverse reactions | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Preferred Pharmaceuticals Inc. | 80d67df3-843d-47bb-85a2-d2f26a824336 | 2026-03-31 | Warnings | G07GZ97H65 |
| RoyceDerm Antifungal Bar | CLOTRIMAZOLE | RoyceDerm LLC | 3abdc4a8-58dd-5bd0-e063-6294a90a1bca | 2026-03-31 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Preferred Pharmaceuticals, Inc. | 624827d6-dbf8-4f3d-a8c0-c92474cad7de | 2026-03-31 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Preferred Pharmaceuticals Inc. | fd010006-f646-46ed-841a-9f247b19e397 | 2026-03-31 | Warnings | G07GZ97H65 |
| Hemorrhoidal | LIDOCAINE, MINERAL OIL, PHENYLEPHRINE HCL, WHITE PETROLATUM | Walgreens Co | 3d213ba8-3cbe-11c4-e063-6394a90ae016 | 2026-03-30 | Warnings | T5L8T28FGP |
| Lasolex Liquid Solution | CLOTRIMAZOLE 1% | PureTek Corporation | 4dc9e64d-8235-b218-e063-6394a90a0157 | 2026-03-24 | Warnings | G07GZ97H65 |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Sun Pharmaceutical Industries, Inc. | 7c96b978-25ff-44c2-bc9c-30ff5e34cffb | 2026-03-23 | Warnings, Adverse reactions | 9IFA5XM7R2 |
| seebeellar clotrimazole 1% antifungal cream | SEEBEELLAR CLOTRIMAZOLE 1% ANTIFUNGAL CREAM | GUANGZHOU YUSONG FINE CHEMICLS Co., Ltd | 4d80e551-76c2-150a-e063-6394a90a7996 | 2026-03-20 | Warnings | G07GZ97H65 |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Preferred Pharmaceuticals Inc. | 50d4763d-5a84-4c45-be06-040c4a527470 | 2026-03-19 | Adverse reactions | 9IFA5XM7R2 |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | Preferred Pharmaceuticals, Inc. | bfa4b6f5-3b66-430a-af41-60e3f12982bc | 2026-03-19 | Adverse reactions | 9IFA5XM7R2 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.